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(PHRI), TB Center, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America, 7 Institut Pasteur de Lille, Lille, France

Abstract
Background: Despite the availability of many animal models for tuberculosis (TB) research, there still exists a need for better
understanding of the quiescent stage of disease observed in many humans. Here, we explored the use of the Wistar rat
model for the study of protective immunity and control of Mycobacterium tuberculosis (Mtb) infection.
Methodology/Principal Findings: The kinetics of bacillary growth, evaluated by the colony stimulating assay (CFU) and the
extent of lung pathology in Mtb infected Wistar rats were dependent on the virulence of the strains and the size of the
infecting inoculums. Bacillary growth control was associated with induction of T helper type 1 (Th1) activation, the
magnitude of which was also Mtb strain and dose dependent. Histopathology analysis of the infected lungs demonstrated
the formation of well organized granulomas comprising epithelioid cells, multinucleated giant cells and foamy
macrophages surrounded by large numbers of lymphocytes. The late stage subclinical form of disease was reactivated
by immunosuppression leading to increased lung CFU.
Conclusion: The Wistar rat is a valuable model for better understanding host-pathogen interactions that result in control of
Mtb infection and potentially establishment of latent TB. These properties together with the ease of manipulation, relatively
low cost and well established use of rats in toxicology and pharmacokinetic analyses make the rat a good animal model for
TB drug discovery.
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organizations have stepped up efforts to develop new drugs that
target both growing as well as non-replicating bacteria, thereby
reducing the probability of development of latent disease.
Many of the advances in our understanding of Mycobacterium
tuberculosis (Mtb) pathogenesis and host immunity to the infecting
bacilli have been achieved through experimental research using
various animal models. These animal models are also indispensable in the process of TB drug development. The mouse model,
the most commonly used animal in TB research, gives rise to a
chronic state in which infection in the lung stabilizes at a high
level, steady state bacillary load. Mice lack some of the features
characteristic of human TB disease including maturation of
granulomas and the development of central necrosis, liquefaction
and cavity formation [5]. Guinea pigs are highly susceptible to

Introduction
The emergence of multidrug-resistant (MDR) Mtb strains and
more recently, extensively drug-resistant (XDR) strains is a serious
health care problem worldwide [1–4]. MDR strains are resistant to
isoniazid (INH) and rifampicin (RIF). XDR strains are defined as
resistant to fluoroquinolones and one of the three injectable drugs
– capreomycin, amikacin and kanamycin, in addition to INH and
RIF. The loss of use of these drugs in patients with MDR or XDR
TB has highlighted the urgent need to develop new therapeutic
interventions with novel targets, to successfully treat drug resistant
TB. Furthermore, the majority of first and second line drugs that
target growing bacilli are less efficient at killing non-replicating
organisms. Therefore, the stop TB partnership and other funding
PLoS ONE | www.plosone.org
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BAL from H37Rv infected animals compared to HN878 infected
animals (Figure 1C).
At this low dose of infection, no granulomas were formed in the
lungs of H37Rv infected rats and very small (0.2 to 0.7 mm2)
granulomas were observed in the lungs of HN878 infected rats
(data not shown). Thus, the accelerated clearance of H37Rv from
the lungs of infected rats was associated with significantly higher
transient Th1 type cytokine production by mononuclear cells
isolated from the infected lungs. These results suggested that
similar to the mouse and rabbit, in the rat, HN878, a Beijing
family clinical isolate of Mtb, is less immunogenic and therefore
more virulent than H37Rv.
To further investigate the rat response to infection with Mtb
Beijing strains, HN878 and W4 (another clinical isolate of the
Beijing family) were used to infect the animals. When about
500 CFU were inoculated into the lungs of rats the two strains
grew similarly for the first 30 days post infection (Figure 2A).
Thereafter, somewhat higher numbers of CFU of HN878
persisted in the lungs of infected rats compared to W4. From 90
to 120 days, lung infection by both strains was partially controlled.
At 180 days no CFU were detected in 4/12 and 7/12 HN878 and
W4 infected rat lungs, respectively. When leukocytes were isolated
from the lungs of infected rats at 30 days post infection and
evaluated for IFN-c production following ex vivo stimulation with
mycobacterial antigens, similar levels of the cytokine were
produced by cells from both groups of rats (Figure 2B).
In response to this dose of infection, granulomas were formed in
the lungs of both W4 and HN878 infected rats (Figure 2C). At 30
days post infection, mixtures of epithelioid and foamy macrophages and lymphocytes were seen in the lung lesions of both
infected groups. However, the pulmonary response to W4
infection included discrete granulomas surrounded by significant
alveolar cell wall thickening which was much reduced in the lungs
of HN878 infected rats. In conclusion, both Beijing strains induced
similar levels of T cell activation as determined by IFN-c
production at 30 days. However, a reduced control of the
HN878 infection with higher bacillary loads at the later time
points was noted. These results suggest that even relatively small
differences Mtb strains, not always well defined, can give rise to
differential responses to pulmonary infection. Moreover, these
results also suggest that the HN878 inocula size determines the
extent of pathology seen in the lungs of infected animals (Figure 2
versus data described in the text for low dose HN878 infection).

Mtb infection: a single bacillus can cause fatal disease within
several months [6]. In these animals central necrosis is seen in the
granulomas. Rabbits, historically considered to be resistant to Mtb
infection, have recently been shown to develop chronic progressive
granulomatous disease or control of infection depending on the
virulence of the Mtb strains used for infection [7,8]. The major
advantage of this model is the resemblance of the histopathology of
granuloma formation and maturation (necrosis, liquefaction and
cavity formation) to human disease [9]. However, there is a
paucity of commercially available immunologic reagents for the
rabbit. The animal model that mimics most accurately the full
spectrum of TB infection and disease in humans is the low dose
pulmonary infection of Cynomologus macaques [10]. Solid,
necrotic or cavitary granulomas are frequently observed within
the same monkey. Further, about 50% of monkeys show clinical
characteristics of latent TB [11]. Unfortunately, this model has the
disadvantage of high cost and complex bio-containment considerations. These animal models, while addressing many aspects of
human TB disease, lack a cheap and convenient model for
studying latent infection and for testing new anti-TB drugs
targeting non-replicating persistent Mtb.
Rats have been shown to be highly resistant to Mtb. Early
studies suggested that infection with a high dose of Mtb could
neither kill the rats nor produce typical TB lesions and tuberculin
sensitivity [12,13]. Later reports found that Mtb could disseminate
to different organs in the rat and cause delayed type hypersensitivity responses to tuberculin, similar to observations in some
strains of mice [14–16]. Lefford and colleagues showed that Mtb
infected rats mount a rapid and specific immune response [17].
Recent studies on the rat have reported on the histopathology and
bacillary load in the lungs of Mtb infected animals [18–20]. In the
present study we explored the features of the Wistar rat model of
Mtb infection and disease. Our results show that the containment
of the disease and the characteristics of the host response to Mtb
infection are both strain and dose dependent.

Results
The effect of Mtb strain on the response to infection in
the lungs of Wistar rats
Six-week old female Wistar rats were infected with a low dose of
the laboratory strain H37Rv or the clinical isolate HN878 and the
bacillary load in the lung was evaluated over time. Similar growth
of the bacilli was seen during the first three weeks of infection with
either strain (Figure 1A). Thereafter, H37Rv bacillary counts
dropped, below the level of detection (LOD) between 60 and 120
days post infection. In contrast, HN878 CFU numbers remained
elevated in the lungs up to 60 days post infection, followed by a
variable reduction in the numbers of organisms by 120 days.
Similar low HN878 bacillary loads and H37Rv clearance were still
seen at 240 days post infection (data not shown).
The differential efficacy of clearance of H37Rv versus HN878
was associated with different levels of IFN-c production by cells
isolated from the lungs and stimulated ex vivo with mycobacterial
antigens. Up to 28 days post infection, cells isolated from H37Rv
infected rat lungs produced increasing levels of IFN-c when
stimulated with ESAT-6+CFP-10 or PPD (Figure 1B). In contrast,
cells isolated from the lungs of low dose HN878 infected rats
produced consistently lower levels of the IFN-c. By 60 and 120
days post infection, similar low levels of IFN-c were produced by
cells from the lungs of both groups of rats. When the BAL fluid of
infected rats was evaluated for the presence of IFN-c and MCP-1,
a similar differential response was noted. Both IFN-c and MCP-1
were present at higher concentrations at early time points in the
PLoS ONE | www.plosone.org

The effect of W4 inocula size on the response to infection
in the lungs of Wistar rats
To more carefully evaluate the effect of inocula size on the rat
response to pulmonary Mtb infection, animals were inoculated
with four different starting inocula, from 101 to 104 CFU of strain
W4. The profiles of lung bacillary loads from two independent
experiments are shown in Figure 3A. Bacillary growth was noted
in response to infection with all inocula, peaking at 21 days post
infection. Thereafter, a similar slow and steady decline in bacillary
load was observed in the lungs of all four groups of rats by 60 days
post infection. Enumeration of the bacillary load was also
performed in different organs of the infected Wistar rats. No
bacilli were recovered from the brain, blood, kidney and liver of
the infected animals at any time points. However, sporadic
bacterial dissemination to the spleen of infected animals was
observed at 21 and 28 days. By 60 days post infection, no bacilli
were found in any evaluated organs other than the lung (data not
shown). Cells isolated from the spleen and blood of infected rats at
30 days post infection were evaluated for proliferation in response
to ex vivo stimulation with ESAT-6+CFP-10. A clear inocula dose
2
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Figure 1. Bacillary load and extent of Th1 response in the lungs of Wistar rats infected by the endotracheal route with Mycobacterium
tuberculosis. A, Number of Mtb colony-forming units in the lungs of rats infected with HN878 or H37Rv. The difference in Mtb load between the two
strains at day 14 and 60 was significant (P,0.005). Values are means 6 SD. B, Interferon gamma (IFN-c) production by lung cells from Mtb infected rats
following ex vivo stimulation with ESAT6+CFP10 and PPD antigens. Values are means 6 SE. C, IFN-c and monocyte chemotactic protein-1 (MCP-1) levels
in the BAL fluid of rats infected with HN878 and H37Rv. Values are means 6 SEs. (*P,0.05, ** P,0.01, *** P,0.001).
doi:10.1371/journal.pone.0018632.g001

infiltration but no structured granuloma formation during the first
60 days of infection (data not shown). The intermediary inocula of
103 gave rise to delayed formation of small (about 0.4 to 0.5 mm2)
granulomas at 28 and 60 days post infection (Figure 4). The
highest dose of infection gave rise to well organized small
granulomas that on average increased in size from about

response was noted. Spleen and blood cells of animals infected
with the highest dose gave rise to more extensive proliferation
compared to lower dose inoculation (Figure 3B).
Examination of the lungs of infected animals also showed a clear
inocula dose response in terms of infection-induced pathology.
The two lower doses of infection resulted in diffused cellular
PLoS ONE | www.plosone.org
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Figure 2. Response to infection of Wistar rats with two closely related Beijing Mtb strains. A, Pulmonary bacillary load in Wistar rats
infected with HN878 or W4. Values are means 6 SDs. The difference in Mtb load between both strains at day 90 (P = 0.001) and 180 (P = 0.019) was
significant. B, Interferon gamma (IFN-c) production by lung cells from Mtb infected rats following ex vivo stimulation with ESAT6+CFP10 or Ag85A
antigens at day 30 post infection. Values are means 6 SE. C, Histopathologic micrographs of lungs of rats infected with M. tuberculosis HN878 versus
W4. (i) Infection with strain HN878, 30 days post infection, H&E, magnification 106. Small, well organized granulomas, demarcated from the rest of
the parenchyma. (ii) Same as (i) at magnification 406. Distinct area rich in macrophages, surrounded by lymphocytes. (iii) Infection with strain W4, 30
days post infection, H&E, magnification 106. Increased alveolar cell wall thickening is seen. (iv) Same as (iii) at magnification 406. Granulomas consist
of macrophages and lymphocytes. (v) Infection with HN878, 90 days post infection, H&E, magnification 406. Well organized granulomas with areas
rich in macrophages surrounded by large numbers of lymphocytes. (vi) Infection with W4, 90 days post infection, H&E, magnification 406. Well
organized granulomas with a higher number of foamy macrophages.
doi:10.1371/journal.pone.0018632.g002

0.6 mm2 to 1.2 mm2 from day 14 to 28 post infection. At day 28,
granulomas had central area of epithelioid macrophages and cuff
of lymphocytes. By 60 days lesions were well structured with many
lymphocytes, foamy macrophages and few multi-nucleated giant
cells. AFB were detected in the lungs of both 104 and 103 infected
rats (not shown). Necrosis and fibrosis were seldom seen. Taken
together these results suggest that the magnitude of the host
immune-pathologic response to Mtb W4 infection was dose
dependent. However, the magnitude of this response did not
determine the efficacy of clearance of the bacilli. Rather, CFU
decreased similarly at all inocula, resulting in 60-day bacillary
loads that were proportional to the initial inocula in each group.

macrophages (Figure 5B). Other better formed granulomas
consisted of mixed lymphocytes, epithelioid cells and Langhans’
type giant cells (Figure 5C and D). Pulmonary lymph nodes from
these animals contained scattered epithelioid histiocytes and
multinucleated giant cell (Figure 5E and F). No AFB and no
calcification were observed in the lungs of these rats.

Immunosuppression mediated reactivation of infection
in Wistar rats
Wistar rats were infected with (100 cfu) Mtb W4 strain for 100
days. To induce reactivation of the bacilli, dexamethasone (2 mg/
l) was given to some of the rats in drinking water from day 100 to
day 130 post-infection. CFU were evaluated in the lungs of the 2
groups at 130 days. The dexamethasone treated rats had more
cultivable bacilli compared to the untreated control animals,
indicating a reduction in protective immunity facilitating the
reactivation of bacillary growth (Figure 6).

Histopathology appearance of lungs during subclinical
infection
By 180 days post infection Mtb HN878 and W4 could only be
detected in some of the animals (see text relevant to Figure 2A)
suggesting a possible late subclinical phase of infection in these
animals. Examination of the lungs from rats with subclinical
infection revealed a spectrum of pathologic appearances ranging
from healthy lung parenchyma (Figure 5A) to exceedingly cellular
tissue. The lungs of some of the animals displayed multiple small
granulomas (0.2 to 0.4 mm2 in size) intermixed with foamy
PLoS ONE | www.plosone.org

Discussion
An evaluation of the course of infection, host immunity and
pathology in the lungs of Mtb-infected Wistar rats has identified
some characteristics, which are different from other animal models
4
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Figure 3. Bacillary load and extent of immune response in Wistar rats infected with different inocula of Mtb W4 strain. A, Number of
Mtb colony-forming units in the lung of rats infected with different inocula of W4. Data from two different experiments are shown. Values are means
6 SD. B, In vitro spleen and blood cell proliferation. Proliferation in response to ESAT6+CFP10 peptides was measured by [3H]thymidine
incorporation. Each bar represents one animal.
doi:10.1371/journal.pone.0018632.g003

of pulmonary TB. Upon low dose infection an increase in bacterial
load associated with the induction of a strong adaptive immune
response peaking by 28 days post infection was noted. Subsequent
control of bacillary growth and thereafter suppression of growth in
the lungs of infected rats was observed. Consequently, by 4 months
post infection, depending upon the strain of Mtb used, the
infection was brought under control and bacilli were eliminated,
or bacillary loads were reduced significantly. This is different to
what is observed in the mouse and the guinea pig but similar to
what is observed in the majority of human hosts, where the
infection is controlled and most individuals do not develop active
disease but rather latent infection [21].
However, not much is known about the transition between
infection in the lung and the establishment of the active or
subclinical disease in humans. Do bacilli multiply first, leading to
the development of an adaptive immune response which in turn
controls and clears the multiplying bacilli and eventually gives rise
to latent disease or is it the host innate immune response that plays
an important role in clinical outcome? It has been reported that
even in the Cynomologus macaque model, which is the
representative animal model depicting human TB, the amount
of gross disease seen at 60 days post-infection could not predict the
establishment of latent disease [22].
Histopathology analysis of the lungs from rats infected with high
inocula revealed several aspects of pathology, which are also
similar to the human response but different from what is
commonly observed in the mouse (Table S1) [23]. The formation
of well organized granulomas containing multi-nucleated giant
PLoS ONE | www.plosone.org

cells is a hallmark of human TB. In addition, resorption of lesions
over time was noted at later time-points when bacilli were no
longer detectable. In some animals foamy macrophages were
frequent at the later time points. Foamy cells have been shown to
be present during the resolution phase of pulmonary lesions [24]
and have recently been proposed as the cells that might constitute
a reservoir for long-term persistence of bacilli within the human
host [25]. It is importatnt to note that in the present study all
animals were infected by the endotracheal route and hence the
lung lesions observed may differ from the pathology which
develops following aerosol infection.
Differential virulence and immunogenicity of Mtb strains,
defined here by the kinetics of bacillary growth and persistence
in the lungs, and the extent of induction of IFN-c production, has
already been demonstrated in other animal models of TB. Using
the rabbit model of tuberculous meningitis, it has been shown that
the laboratory strain H37Rv is less virulent than the clinical
isolates HN878 and W4 (W/Beijing genotype) [8]. The hypervirulence of HN878 appeared to be due to the failure of this strain
to stimulate optimal Th1 type immunity in the mouse model [26].
This appeared to be associated with the production of phenolic
glycolipid (PGL), which is not produced, by H37Rv [27]. Ordway
et al. reported that the HN878 strain induces an initial potent Th1
response in mice followed by rapid down-regulation of this activity
[28]. In the present study we noted that even relatively small
differences among Mtb strains (as seen with the two Beijing isolates
HN878 and W4) gave rise to different responses to the infection in
the rat. Differential lung bacillary load has also been observed in
5
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Figure 4. Histopathology of lungs of rats infected with M. tuberculosis W4, H&E. A, E and I, inoculum 103 CFU, magnification 106; A. Day 14
post infection. Alveolar cell wall thickening is observed. E. Day 28 post infection. Small cellular aggregates are seen. I. Day 60 post infection. Small
granulomas have formed. B, C and D - inoculum 104 CFU, 14 days post infection. B. Small peribronchial cellular aggregates are observed,
magnification 46. C. Magnification 106 and D, The lesions consist of mixed lymphocytes, PMNs and macrophages, magnification 406. F, G and H inoculum 104 CFU, 28 days post infection; magnification 46, 106 and 406 respectively. Small, well organized granulomas with central area of
macrophages and cuff of lymphocytes. J, K and L - inoculum 104 CFU, 60 days post infection; magnification 46, 106 and 406 respectively. Well
structured granulomas with differentiated macrophages.
doi:10.1371/journal.pone.0018632.g004

rabbits infected with HN878 and W4 strains [8]. The interplay
between the virulence of Mtb strain, control of infection and
organization of the granulomas as reported in the present work is
in agreement with a recent study, which describes how pathogenic
mycobacteria exploit the granuloma as a mechanism for expansion
and systemic dissemination [29].
It is difficult to study latency not only due to our lack of
knowledge of the factors, both host and pathogen derived, which
are responsible for the bacilli adopting a non-replicating state but
also it is difficult to demonstrate the presence of latent bacilli in
previously infected tissues [30]. In humans and Cynomologus
macaques, latency has been described as absence of any clinical
symptoms with a positive tuberculin skin test (TST) or T cell IFNc release assays in response to in vitro exposure to mycobacterial
antigens [10,31]. In the Cornell mouse model, latency has been
defined as no detectable CFU following treatment with antibiotics.
PLoS ONE | www.plosone.org

In the present study, we have observed reduction of CFU in the
lungs of infected Wistar rats, to a point where bacilli were not
detected by culture or were only observed at very low numbers. In
this model, reactivation of infection upon immune suppression
provides evidence for the presence of viable bacilli in the tissue
even in animals where bacilli may not have been detected prior to
immune suppression by the CFU assay [32]. Elwood et al. defined
latency in cotton rats as the absence of granulomatous inflammation with positive lung bacillary cultures [33].
One of our aims was to benchmark the Wistar rat model as a
tool to evaluate new anti-TB drugs. Drug efficacy experiments
using the Wistar rat TB model have shown that the relationship
between in vivo efficacy and area under the curve/minimal
inhibitory concentration (AUC/MIC) follows the same trend in
the rat as for other animal models and in patients (MH and VD,
manuscript in preparation). Rats are inexpensive, simple to house
6
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Figure 5. Histology of lungs from rats infected with W4 for 180 days. (A) Normal appearing lung parenchyma, magnification 6.56. (B) Lung
with variable numbers of foamy macrophages, magnification 106. (C) Small granulomas containing lymphocytes and epithelioid cells, magnification
206. (D) A small inflammatory cell aggregate containing a large numbers of lymphocytes and a multinucleated giant cell, magnification 406. (E) An
infiltrated mediastinal lymph node with lymphocytes and epithelioid histiocytes, magnification 6.56. (F) Same as E, magnification 206.
doi:10.1371/journal.pone.0018632.g005

and manipulate, with the added advantage of allowing repeated
blood samplings. These properties favor the use of rats in
statistically representative numbers. Moreover, Wistar rat are
used as the primary species for ADME (Absorption, Distribution,
Metabolism and Excretion) and toxicology studies in early drug
development, with large comparison databases available in the
public domain.
In summary, the Wistar rat offers several promising possibilities
and additions as an animal model for TB. The kinetics of bacillary
growth and control in the lungs, and the histopathology suggest
that Wistar rats are more resistant to Mtb infection than the
mouse. The model will allow us to understand the basic biology of
Mtb from early control of infection to establishment of persistent
disease, the mechanisms of drug diffusion in diverse host tissues,
sterilization of non-replicating bacilli, analysis of drug tolerance
and bacterial adaptability. It may therefore offer a good predictive
and practical in vivo system for the screening of novel anti-TB
drugs.

Materials and Methods
Ethics statement
All animals were maintained in accordance with protocols
approved by the institutional animal ethical committee of ISP
(Comité d’éthique concerté du CERVA, IPB at ISP). The
authorization was approved by SPF Santé publique/FOD
Volksgezondheid DG 4/Div 4: Bien-être animal et CITES Dierenwelzijn en CITES (No LA2230389).

Bacterial strains
Two well characterized clinical isolates of M. tuberculosis (Mtb),
W/Beijing strains HN878 and W4 (TB Center, Public Health
Research Institute, UMDNJ, Newark, NJ, USA) [25,34], and the
laboratory strain H37Rv were used in the experiments
(ATCC25618). The strains were cultured in stationary Sauton
medium in 500 ml cellular culture flasks to mid-log phase, washed,
pelleted, re-suspended in phosphate-buffered saline (PBS), vortex-

Figure 6. Bacillary load in the lungs of rats following immunosuppression. Rats were infected with 102 CFU of M. tuberculosis strain
W4 and either left untreated or treated with dexamethasone for one
month starting at 100 days post- infection. Lung bacillary load was
quantified at 130 days post-infection (* P = 0.025 and 0.036 for exp 1 and
2, respectively).
doi:10.1371/journal.pone.0018632.g006

PLoS ONE | www.plosone.org
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(GIBCO). 200 ml of diluted blood was distributed in quadruplicates into 96-well round-bottom tissue culture plates (Falcon
Labware) and incubated with various antigens for 5 days at 37uC
in 5% CO2-95% air and 100% humidity. The spleen was
homogenized and single cell suspensions (16106 cells) were
cultured in a similar manner. On the evening of the 5th day of
incubation, 0.5 mCi of [3H] thymidine (New England Nuclear,
Boston) was added to each well and the cells were further
incubated overnight at 37uC in 5% CO2-95% air and 100%
humidity. A multi-sample automated cell harvester (Skatron Inc.,
Sterling, Va.) was used to wash each well, and the effluent was
passed through a filtermat (Skatron). [3H] thymidine incorporation
into the cells was measured by liquid scintillation. Stimulation
index was calculated as counts per minute (cpm) of cells stimulated
with antigen divided by cpm of cells stimulated with RPMI alone.

ed with 2 mm glass beads, left to settle and the supernatant was
filtered through a 5 mm membrane. Subsequently the supernatant
was transferred to a fresh tube for further washing/pelleting and
finally adjusted in PBS/glycerol to an OD600 of 1.2 corresponding
to approximately 26108 CFU/ml. The bacillary suspension was
dispensed into aliquots and stored at 280uC. After one day an
aliquot was thawed and bacilli were plated on 7H11 plates for
CFU enumeration.

Rats
Specific pathogen free (SPF) 6 week old outbred female Wistar Rats
(Crl:WI) were purchased from Charles River, France. The animals
were maintained in cages under biosafety-level-3 conditions at the
Institute for Scientific Public Health (ISP), Brussels, Belgium.
Throughout the experiments animals were fed sterile irradiated food
and sterile water ad libitum. For immunosuppression rats were
administered dexamethasone (2 mg/l) in drinking water [35].

Cytokine/chemokine estimation in broncho-alveolar
lavage (BAL) fluid

Endotracheal inoculation of rats with Mtb

BAL was collected from the animals before excising the lungs
from the chest cavity. Lungs were washed with 2.5 ml of 1x PBS to
retrieve the BAL, the fluid was centrifuged and cytokines/
chemokines were estimated in the BAL fluid using a multiplex
flowcytomix kit (Bender MedSystems).

Animals were anaesthetized by intraperitoneal injection with a
cocktail consisting of ketamine: 75 mg/kg; diazepam: 1.2 mg/kg
and atropine: 0.4 mg/kg and infected endotracheally as described
[36]. Briefly, the inocula were deposited directly at the carina, the
sternal angle of the bronchi, by passing a plastic needle through
the mouth and trachea of the anaesthetized animal. This noninvasive technique has proven to be highly precise and consistent.

Lung cell digestion
At the indicated time points following infection, rats were
euthanized; lungs were aseptically removed from the pulmonary
cavity, placed in RPMI-1640 medium and dissected. The dissected
lung tissue was incubated with incomplete RPMI-1640 containing
collagenase XI (1 mg/ml, Sigma) and type IV bovine pancreatic
DNAse (30 mg/ml, Sigma) for 1 hr at 37uC under shaking
condition. The digested lungs were disrupted by gently pushing
the tissue through a cell strainer (100 mm, BD Biosciences). RBC’s
were lysed with RBC lyses buffer (Sigma), washed and lung cells
were re-suspended in complete RPMI-1640 and total cell numbers
were determined.

Enumeration of mycobacteria in organs
At pre-determined time points post-infection rats were euthanized with sodium pentobarbital (55 mg/kg). One ml of blood was
collected and diluted in PBS for colony forming unit (CFU) assay
for each animal. In addition, the left lung or the whole lung, liver,
kidneys, spleen and brain were all aseptically excised, washed in
PBS and homogenized using a tissue homogenizer (Idea Works
Laboratory Devices, Syracuse, NY). Bacterial counts in the organs
of infected rats (n = 3–12 per treatment group) at each time point
were determined by plating serial dilutions of tissue homogenates
or blood on 7H11 agar plates and enumerating CFU after 3–4
weeks of incubation at 37uC.

In vitro interferon gamma (IFN-c) measurement
Lung cells (16106 cells) were incubated with different antigens
for 72 hr at 37uC in 5% CO2-95% air. After incubation,
supernatants were frozen at 280uC until processed for IFN-c
measurement using an ELISA kit according to the manufacturer’s
instruction (eBioscience).

Histopathology and morphometric evaluation of
granulomas
Segments of the lungs (3 animal/time point) were fixed with
10% neutral formalin, embedded in paraffin and processed for
histology (N = 3/time point). Sections (5 mm) were stained with (i)
hematoxylin-eosin-safran (HES), (ii) Sirius red and/or VolgensGomori (collagen types I and III for analysis of fibrosis), and (iii)
Ziehl-Neelsen stain for acid-fast bacilli (AFB). Histologic sections
were used for morphologic analysis of the size and number of
granulomas at different time points post infection.

Statistical analysis
All values were expressed as means 6 SD or means 6 SE. Two
groups were compared using Student’s t-test. Multiple groups were
compared using one way ANOVA and Bonferroni’s multiple
comparison tests. All statistical analysis was carried out using
GraphPad PRISM software. For statistical analysis a P value
,0.05 was considered to be statistically significant.

Antigens
ESAT6+CFP10 fusion protein, PPD and recombinant antigen
85A (final concentration 5 mg/ml) were used for the lymphoproliferation assay and IFN-c production. Concanavalin A and
pokeweed mitogen (final concentration 4 mg/ml) were used as
positive controls.

Table S1 Comparison of TB pathology in Wistar rats with other
animal models and human.
(DOC)

Lymphoproliferation assay

Acknowledgments

The assay was performed as described previously [37]. Blood
(1 ml) from each animal was collected into a heparinized tube and
diluted with RPMI containing penicillin (100 U/ml), streptomycin
(100 pg/ml), b-mercaptoethanol and 10% fetal calf serum

This work was initiated at the Pasteur Institute, Lille-France (EMA & PB)
and continued at Pasteur-Brussels, Belgium (now Scientific Institute of
Public Health) and the Novartis Institute for Tropical Diseases, Singapore.
We thank Kris Huygen for the antigens.

PLoS ONE | www.plosone.org

Supporting Information

8

April 2011 | Volume 6 | Issue 4 | e18632

The Wistar Rat: Alternative Model in TB Research

MR. Analyzed the data: AS EMA GK PB. Contributed reagents/
materials/analysis tools: MH LC DF HCT JYS GK. Wrote the paper: AS
GK PB BM.

Author Contributions
Conceived and designed the experiments: AS EMA VD PB BM.
Performed the experiments: AS EMA VM MK CC BD LT LF JB WB

References
1. Migliori GB, Matteelli A, Cirillo D, Pai M (2008) Diagnosis of multidrugresistant tuberculosis and extensively drug-resistant tuberculosis: Current
standards and challenges. Can J Infect Dis Med Microbiol 19: 169–172.
2. Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, et al. (2007) Worldwide
emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 13:
380–387.
3. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC (2007) 125 years after
Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is
‘‘science’’ enough to tackle the epidemic? Eur Respir J 29: 423–427.
4. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, et al. (2006)
Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194: 479–485.
5. Flynn JL, Chan J (2003) Animal models of tuberculosis. In: Rom SMG, ed.
Tuberculosis. 2nd edn. Philadelphia: Lippincott, Williams & Wilkins. pp
237–250.
6. McMurray DN (1994) Guinea pig model of tuberculosis. In: Bloom BR, ed.
Tuberculosis: pathogenesis, protection and control. Washington, SC: ASM
Press. pp 135–147.
7. Dannenberg AM (1994) Rabbit model of tuberculosis. In: Bloom BR, ed.
Tuberculosis: pathogenosis, protection and control. Washington, SC: ASM
Press. pp 135–147.
8. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, et al. (2005)
Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit
model of meningitis is dependent on phenolic glycolipid produced by the bacilli.
J Infect Dis 192: 98–106.
9. Flynn JL, Tsenova L, Izzo A, Kaplan G (2008) Experimental Animal Models of
Tuberculosis. In: Kaufmann SH, Britton WJ, eds. Handbook of Tuberculosis:
Immunology and Cell Biology. Weinheim: WILEY-VCH Verlag GmbH & Co.
KGaA.
10. Capuano SV, 3rd, Croix DA, Pawar S, Zinovik A, Myers A, et al. (2003)
Experimental Mycobacterium tuberculosis infection of cynomolgus macaques
closely resembles the various manifestations of human M. tuberculosis infection.
Infect Immun 71: 5831–5844.
11. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, et al. (2009) Quantitative
comparison of active and latent tuberculosis in the cynomolgus macaque model.
Infect Immun.
12. Glyone SR, Page DS (1923) The reaction to B. tuberculosis in the albino rat.
J Pathol Bacteriol 26: 224–233.
13. Ornstein GB, Steinbach MM (1925) The resistance of the albino rat to infection
with tubercle bacilli. Am Rev Tuberc 12: 77–86.
14. Wessels CC (1941) Tuberculosis in the rat. II. The fate of tubercle bacilli in the
various organs of the rat. Am Rev Tuberc 43: 459–474.
15. Flax MH, Waksman BH (1962) Delayed cutaneous reactions in the rat.
J Immunol 89: 496–504.
16. Gray DF (1961) The relative natural resistance of rats and mice to experimental
pulmonary tuberculosis. J Hyg (Lond) 59: 471–477.
17. Lefford MJ, McGregor DD, Mackaness GB (1973) Immune response to
Mycobacterium tuberculosis in rats. Infect Immun 8: 182–189.
18. Sugawara I, Yamada H, Mizuno S (2004) Pathological and immunological
profiles of rat tuberculosis. Int J Exp Pathol 85: 125–134.
19. Sugawara I, Yamada H, Mizuno S (2004) Pulmonary tuberculosis in
spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204: 135–145.
20. Sugawara I, Yamada H, Mizuno S (2006) Nude rat (F344/N-rnu) tuberculosis.
Cell Microbiol 8: 661–667.

PLoS ONE | www.plosone.org

21. Young D (2009) Animal models of tuberculosis. Eur J Immunol 39: 2011–2014.
22. Lin PL, Flynn JL (2010) Understanding latent tuberculosis: A moving target.
J Immunol 185: 15–22.
23. Basaraba RJ (2008) Experimental tuberculosis: the role of comparative
pathology in the discovery of improved tuberculosis treatment strategies.
Tuberculosis (Edinb) 88(Suppl 1): S35–47.
24. Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DW, Jr., et al.
(1983) Lipid bodies: cytoplasmic organelles important to arachidonate
metabolism in macrophages and mast cells. J Immunol 131: 2965–2976.
25. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, et al. (2008) Foamy
macrophages from tuberculous patients’ granulomas constitute a nutrient-rich
reservoir for M. tuberculosis persistence. PLoS Pathog 4: e1000204.
26. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. (2001) Virulence
of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure
to induce Th1 type immunity and is associated with induction of IFN-alpha/
beta. Proc Natl Acad Sci U S A 98: 5752–5757.
27. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid
of hypervirulent tuberculosis strains that inhibits the innate immune response.
Nature 431: 84–87.
28. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, et al. (2007)
The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent
TH1 response followed by rapid down-regulation. J Immunol 179: 522–531.
29. Davis JM, Ramakrishnan L (2009) The role of the granuloma in expansion and
dissemination of early tuberculous infection. Cell 136: 37–49.
30. Orme M (2001) The latent tuberculosis bacillus (I’ll let you know if I ever meet
one). Int J Tuberc Lung Dis 5: 589–593.
31. Rothel JS, Andersen P (2005) Diagnosis of latent Mycobacterium tuberculosis
infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect
Ther 3: 981–993.
32. McCune RM, Tompsett R, Jr. (1956) Fate of Mycobacterium tuberculosis in
mouse tissues as determined by the microbial enumeration technique. I. The
persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged
antimicrobial therapy. J Exp Med 104: 737–762.
33. Elwood RL, Rajnik M, Wilson S, Yim K, Blanco JC, et al. (2009)
Characterization of late tuberculosis infection in Sigmodon hispidus. Tuberculosis (Edinb) 89: 183–188.
34. Bifani PJ, Mathema B, Liu Z, Moghazeh SL, Shopsin B, et al. (1999)
Identification of a W variant outbreak of Mycobacterium tuberculosis via
population-based molecular epidemiology. JAMA 282: 2321–2327.
35. Jimenez E, Martı́nez A, Aliouat el M, Caballero J, Dei-Cas E, Gargallo-Viola D
(2002) Therapeutic efficacies of GW471552 and GW471558, two new
azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat
models. Antimicrob Agents Chemother 46: 2648–2650.
36. Singhal A, Aliouat EM, Creusy C, Kaplan G, Bifani PJ (2010) Pulmonary
tuberculosis in rats. In: Leong JF, Dartois V, Dick T, eds. A color atlas of
comparative pathology of pulmonary tuberculosis Routledge, Taylor and
Francis Inc. pp 157–173.
37. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J,
(1988) Specific lymphoproliferation, gamma interferon production, and serum
immunoglobulin G directed against a purified 32 kDa mycobacterial protein
antigen (P32) in patients with active tuberculosis. Scand J Immunol 27: 187–194.

9

April 2011 | Volume 6 | Issue 4 | e18632

